📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Resverlogix

1.1 - Company Overview

Resverlogix Logo

Resverlogix

Headquarter: Canada
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical therapeutics focused on cardiovascular diseases and Alzheimer’s disease, developing apabetalone, a BET protein-inhibiting small molecule targeting cardiovascular disease, diabetes, chronic kidney disease, and vascular cognitive impairment; runs clinical programs including Phase 3 BETonMACE and planned BETonRENAL; supports commercialization via EVERSANA, Shenzhen Hepalink, and Medison Pharma partnerships.

Products and services

  • BETonMACE: A Phase 3 clinical trial evaluating apabetalone’s ability to reduce major adverse cardiac events in high-risk type 2 diabetes mellitus patients with coronary artery disease
  • EVERSANA Partnership: A commercial-scale collaboration to support apabetalone’s commercialization for COVID-19 and other conditions across the United States, Canada, and potentially broader global markets
  • Apabetalone: A small-molecule therapeutic candidate that inhibits BET proteins to modulate disease-causing genes, targeting cardiovascular disease, diabetes, chronic kidney disease, and vascular cognitive impairment

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Resverlogix

Cameron Health Logo

Cameron Health

HQ: United States Website
  • Description: Provider of implantable defibrillators, operating as a development-stage medical device company that develops, manufactures, and distributes next-generation implantable electronic devices utilizing state-of-the-art technologies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cameron Health company profile →
Micro Interventional Devices Logo

Micro Interventional Devices

HQ: United States Website
  • Description: Provider of percutaneous and minimally invasive structural heart repair technologies, including PolyCor polymeric anchors for soft-tissue cardiac applications; the MIA-T and MIA-M percutaneous annuloplasty systems for tricuspid and mitral valve regurgitation; and the Transcatheter Cardiac Repair platform enabling catheter-based treatment of structural heart disease without cardiopulmonary bypass.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Micro Interventional Devices company profile →
BioCardia Logo

BioCardia

HQ: United States Website
  • Description: Provider of clinical-stage regenerative cardiology therapies and delivery systems, including CardiAMP autologous bone marrow cell therapy for heart failure, CardiALLO allogeneic mesenchymal stem cell therapy, the Helix system for minimally invasive biologic delivery to the heart, Morph DNA FDA-approved steerable introducer sheaths for cardiac/peripheral procedures, and the AVANCE bi-directional steerable introducer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioCardia company profile →
Tissium Logo

Tissium

HQ: France Website
  • Description: Provider of synthetic, biodegradable, light-activated sealants, surgical adhesives, and biomaterial solutions for wound closure and tissue reconstruction, with a focus on minimally invasive surgery. Offerings include SETALIUM Vascular Sealant, ECLIPSIUM laparoscopic hernia repair system, biomorphic programmable polymers, IBD fistula-healing solutions, and COAPTIUM Connect for sutureless nerve repair.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tissium company profile →
CorFlow Therapeutics Logo

CorFlow Therapeutics

HQ: Switzerland Website
  • Description: Provider of proprietary medtech technologies to diagnose and treat microvascular obstructions (MVO) in heart attack patients. Offers the CoFI System for post-PCI coronary microcirculation assessment and controlled infusion of diagnostic/therapeutic agents, the CoFI Console acting as an infusion pump and displaying physiological parameters, an infusion-occlusion CoFI Catheter, and a single-use CoFI Cassette.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CorFlow Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Resverlogix

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Resverlogix

2.2 - Growth funds investing in similar companies to Resverlogix

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Resverlogix

4.2 - Public trading comparable groups for Resverlogix

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Resverlogix

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Resverlogix

What does Resverlogix do?

Resverlogix is a provider of biopharmaceutical therapeutics focused on cardiovascular diseases and Alzheimer’s disease, developing apabetalone, a BET protein-inhibiting small molecule targeting cardiovascular disease, diabetes, chronic kidney disease, and vascular cognitive impairment; runs clinical programs including Phase 3 BETonMACE and planned BETonRENAL; supports commercialization via EVERSANA, Shenzhen Hepalink, and Medison Pharma partnerships.

Who are Resverlogix's competitors?

Resverlogix's competitors and similar companies include Cameron Health, Micro Interventional Devices, BioCardia, Tissium, and CorFlow Therapeutics.

Where is Resverlogix headquartered?

Resverlogix is headquartered in Canada.

How many employees does Resverlogix have?

Resverlogix has 1,000 employees 🔒.

When was Resverlogix founded?

Resverlogix was founded in 2010 🔒.

What sector and industry vertical is Resverlogix in?

Resverlogix is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Resverlogix

Who are the top strategic acquirers in Resverlogix's sector and industry

Top strategic M&A buyers and acquirers in Resverlogix's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Resverlogix?

Top strategic M&A buyers groups and sectors for Resverlogix include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Resverlogix's sector and industry vertical

Which are the top PE firms investing in Resverlogix's sector and industry vertical?

Top PE firms investing in Resverlogix's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Resverlogix's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Resverlogix's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Resverlogix's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Resverlogix include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Resverlogix's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Resverlogix?

The key public trading comparables and valuation benchmarks for Resverlogix include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Resverlogix for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Resverlogix with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Resverlogix's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Resverlogix with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Resverlogix's' sector and industry vertical?

Access recent funding rounds and capital raises in Resverlogix's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Resverlogix